Memo Therapeutics AG and Northway Biotechpharma sign a Development and Manufacturing AgreementDevelopment and Manufacturing Agreement • June 25th, 2020
Contract Type FiledJune 25th, 2020Zurich, Switzerland, and Vilnius, Lithuania – June 25, 2020 – Memo Therapeutics AG and Northway Biotechpharma, a leading biopharmaceutical Contract Development and Manufacturing Organization (CDMO), have signed a Development and Manufacturing Agreement for a therapeutic antibody.